Ind-Swift Laboratories Ltd receives GMP compliance certificate from NNGYK-Hungary

The Global Business Unit (Formulations Facility) of Ind-Swift Laboratories Limited at Village Jawaharpur, Derabassi, Punjab, has received a certificate of GMP compliance from National Center for Public Health and Pharmacy (NNGYK-Hungary), following an EUDRA GMP inspection that was conducted in November, 2025. The said certificate is valid for a period of 3 (Three) years and opens up the European and other markets for the Company's products.

Our Global business unit already holds certifications from WHO-GMP, TGA (Australia), MHRA (UK), SAPRA (South Africa) and EU-GMP.

This achievement reinforces our unwavering commitment to maintaining the highest standards of quality, safety, and regulatory compliance across all our operations. It stands as a testament to our dedication to excellence and our continued focus on meeting the stringent requirements of global regulatory authorities.

Shares of Ind-Swift Laboratories Limited was last trading in BSE at Rs. 97.41 as compared to the previous close of Rs. 97.25. The total number of shares traded during the day was 6678 in over 143 trades.

The stock hit an intraday high of Rs. 109.00 and intraday low of 95.27. The net turnover during the day was Rs. 647172.00.

Source : Equity Bulls

Keywords

IndSwiftLaboratories INE915B01019 Pharmaceuticals GMP ComplianceCertificate NNGYK Hungary